Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is the most common form of irreversible blindness in developed countries. Variants in the factor H gene (CFH, also known as HF1), which encodes a major inhibitor of the alternative complement pathway, are associated with the risk for developing AMD. Here we test the hypothesis that variation in genes encoding other regulatory proteins of the same pathway is associated with AMD. We screened factor B (BF) and complement component 2 (C2) genes, located in the major histocompatibility complex class III region, for genetic variation in two independent cohorts comprising approximately 900 individuals with AMD and approximately 400 matched controls. Haplotype analyses identify a statistically significant common risk haplotype (H1) and two protective haplotypes. The L9H variant of BF and the E318D variant of C2 (H10), as well as a variant in intron 10 of C2 and the R32Q variant of BF (H7), confer a significantly reduced risk of AMD (odds ratio = 0.45 and 0.36, respectively). Combined analysis of the C2 and BF haplotypes and CFH variants shows that variation in the two loci can predict the clinical outcome in 74% of the affected individuals and 56% of the controls. These data expand and refine our understanding of the genetic risk for AMD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This analysis resulted in the identification of the previously well documented independently associated variants near CFH and C2/CFB8,10,31,32 and of additional independent signals near C3, CETP, LIPC, FRK/COL10A1, IER3/DDR1, RAD51B (Supplementary Table 6).”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Genes in the complement pathway4–11 and a region of chromosome 10 12,13 have now been implicated as the major genetic contributors to disease.”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“These include complement 2 (C2) and/or complement factor B (CFB) (56), complement 3 (C3) (170), and complement factor I (CFI) (44).”
From Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration (2009) · cites this paper as [56]
In the citing paper
“studies have demonstrated that at least one of the two variants associated with AMD—R32Q BF—leads to an impairment in the complement activating function of BF (Gold et al., 2006).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Gold et al., 2006
In the citing paper
“the L9H BF/E318D C2 and R32Q BF/intronic variants of C2 have been shown to be protective for AMD (odds ratio (OR) = 0.45 and 0.36, respectively) by Gold et al.”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Gold et al., 2006
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 1×
“Overall type I error rates (α) were retrospectively calculated using a previously described metho”
MethodComplement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
Complement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449
Complement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424
Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961
Self-citationBird, A. C., Bressler, N. M., Bressler, S. B., Chisholm, I. H., Coscas, G., Davis, M. D., de Jong, P. T. V. M., Klaver, C. C. W., Klein, B. E. K., Klein, R., et al. (1995) · Survey of Ophthalmology · doi:10.1016/s0039-6257(05)80092-x · Cited by 1,926
Hageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265
Self-citationDrusen proteome analysis: an approach to the etiology of age-related macular degeneration
Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222551899 · Cited by 1,208
A Fine-Scale Map of Recombination Rates and Hotspots Across the Human Genome
Myers, S., Bottolo, L., Freeman, C., McVean, G., & Donnelly, P. (2005) · Science · doi:10.1126/science.1117196 · Cited by 1,134 · cited 1×
“Fourth, estimated recombination rates from HapMap data indicate regions of high recombination on both sides of the C2/BF locu”
BackgroundA role for local inflammation in the formation of drusen in the aging eye
Anderson, D. H., Mullins, R. F., Hageman, G. S., & Johnson, L. V. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01624-0 · Cited by 1,087
Self-citation
Cited by
Items 401–500 of 1,000
Fucoidan as a Potential Therapeutic for Major Blinding Diseases—A Hypothesis
Klettner, A. (2016) · Marine Drugs · doi:10.3390/md14020031 · Cited by 47
Borucki, D. M., Toutonji, A., Couch, C., Mallah, K., Rohrer, B., & Tomlinson, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.566892 · Cited by 50
New and Innovative Treatments for Neovascular Age-Related Macular Degeneration (nAMD)
Patel, P. N., & Sheth, V. S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112436 · Cited by 48
Chu, J., Zhou, C., Lü, N., Zhang, X., & Dong, F.-T. (2008) · Chinese Medical Journal · doi:10.1097/00029330-200812020-00011 · Cited by 49
Brantley, M. A., Edelstein, S. L., King, J. M., Apte, R. S., Kymes, S. M., & Shiels, A. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.05.018 · Cited by 47
Kaur, I., Ghanekar, Y., & Chakrabarti, S. (2008) · International Journal of Human Genetics · doi:10.1080/09723757.2008.11886028 · Cited by 46
“b) Factor B and Complement Component 2: Recently, Gold et al. (2006), reported a strong association of variation in the Factor B (BF) and complement component 2 (C2) genes with AMD.”
BackgroundInfluentialAssociation ofCFHandCFBGene Polymorphisms with Retinopathy in Type 2 Diabetic Patients
Jun, W., Yang, M. M., Li, Y. B., Liu, G., Teng, Y., & Liu, X. M. (2013) · Mediators of Inflammation · doi:10.1155/2013/748435 · Cited by 45
Xing, C., Sivakumaran, T. A., Wang, J. J., Rochtchina, E., Joshi, T., Smith, W. T., Mitchell, P., & Iyengar, S. K. (2008) · Genes and Immunity · doi:10.1038/gene.2008.10 · Cited by 47
Radu, R. A., Hu, J., Jiang, Z., & Bok, D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.548669 · Cited by 44
Age- and Light-Dependent Development of Localised Retinal Atrophy in CCL2−/−CX3CR1GFP/GFP Mice
Chen, M., Hombrebueno, J. R., Luo, C., Penalva, R., Zhao, J., Colhoun, L., Pandi, S. P. S., Forrester, J. V., & Xu, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061381 · Cited by 42
“Genetic studies have shown that the risk of AMD is related to polymorphisms of a number of immune related genes, including complement factor H (CFH)[7–10], complement component 2 and factor B (C2/CFB) [11], complement component 3 (C3)[12–14], Toll-like receptor (TLRs) [15], and fractalkine receptor (CX3CR1) genes[16–1…”
BackgroundSpencer, K. L., Olson, L. M., Schnetz‐Boutaud, N. C., Gallins, P. J., Agarwal, A., Iannaccone, A., Kritchevsky, S. B., García, M., Nalls, M. A., Newman, A. B., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017784 · Cited by 44
“are now well-accepted risk factors for AMD, and CFB R32Q is associated with decreased AMD risk”
BackgroundMunch, I. C., Ek, J., Kessel, L., Sander, B., Almind, G. J., Brøndum‐Nielsen, K., Linneberg, A. R., & Larsen, M. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4482 · Cited by 46
Batıoğlu, F., Oğuz, Y. G., Demirel, S., & Özmert, E. (2014) · Ophthalmic Research · doi:10.1159/000361077 · Cited by 47
Relevance of Complement Factor H–Related 1 (CFHR1) Genotypes in Age-Related Macular Degeneration
Martínez-Barricarte, R., Recalde, S., Fernández-Robredo, P., Millán, I., Olavarrieta, L., Viñuela, A., Pérez-Pérez, J., García-Layana, A., & Rodríguez de Córdoba, S. (2012) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.11-8709 · Cited by 43
Drusen maculopathy: a risk factor for visual deterioration
Algvere, P. V., Kvanta, A., & Seregard, S. (2016) · Acta Ophthalmologica · doi:10.1111/aos.13011 · Cited by 49
“The alternative complement system, including CFH, operates within the drusen or extracellular deposits (Haines et al. 2005; Gold et al. 2006).”
BackgroundMolecular Genetic Mechanisms in Age-Related Macular Degeneration
Shughoury, A., Sevgi, D. D., & Ciulla, T. A. (2022) · Genes · doi:10.3390/genes13071233 · Cited by 47
“C2 and CFB are expressed in the neural retina, Bruch’s membrane, and choroid [143], and function as activators of the classical and alternative complement cascades, respectively [148].”
BackgroundComplement factor I: Regulatory nexus, driver of immunopathology, and therapeutic
Hallam, T. M., Sharp, S. J., Andreadi, A., & Kavanagh, D. (2023) · Immunobiology · doi:10.1016/j.imbio.2023.152410 · Cited by 45
van de Ven, J. P. H., Boon, C. J. F., Fauser, S., Hoefsloot, L. H., Smailhodzic, D., Schoenmaker-Koller, F. E., Klevering, B. J., Klaver, C. C. W., den Hollander, A. I., & Hoyng, C. B. (2012) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2012.265 · Cited by 49
Fritsche, L. G., Freitag-Wolf, S., Bettecken, T., Meitinger, T., Keilhauer, C. N., Krawczak, M., & Weber, B. H. F. (2009) · Human Mutation · doi:10.1002/humu.20957 · Cited by 42
“This is further supported by strong association of AMD with variants in the complement component 2 (C2; MIM# 217000) and factor B (CBF; MIM# 138470) [Gold et al., 2006; Jakobsdottir et al., 2008; Maller et al., 2006; Spencer et al., 2007] as well as component 3 (C3; MIM# 120700) genes [Maller et…”
BackgroundAMD-like retinopathy associated with intravenous iron
Song, D., Kanu, L. N., Li, Y., Kelly, K. L., Bhuyan, R. K., Alemán, T. S., Morgan, J. I. W., & Dunaief, J. L. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.08.008 · Cited by 44
“…in genes encoding several complement cascade inhibitors – including complement factor H, complement component 2, and complement factor B – have been shown to significantly increase the risk of developing AMD (Klein et al., 2005; Hageman et al., 2005; Gold et al., 2006; McKay et al., 2009).”
BackgroundEdwards, A. O., Fridley, B. L., James, K. M., Sharma, A. K., Cunningham, J. M., & Tosakulwong, N. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003813 · Cited by 44
Leveziel, N., Zerbib, J., Richard, F., Querques, G., Morineau, G., Fremeaux-Bacchi, V., Coscas, G., Soubrane, G., Benlian, P., & Souied, E. H. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1540 · Cited by 43
Age-Related Decline in VIP-Positive Parasympathetic Nerve Fibers in the Human Submacular Choroid
Jablonski, M. M., Iannaccone, A., Reynolds, D., Gallaher, P., Allen, S., Wang, X., & Reiner, A. J. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0972 · Cited by 44
Qin, S., & Rodrigues, G. A. (2008) · Journal of Inflammation Research · doi:10.2147/jir.s4354 · Cited by 45
“A similar result is obtained in the combined Columbia and Iowa cohorts with 551 cases and 269 controls (OR 0.32) (Gold et al 2006).”
InfluentialThe Complement Component 5 Gene and Age-Related Macular Degeneration
Baas, D. C., Ho, L., Ennis, S., Merriam, J. E., Tanck, M. W. T., Uitterlinden, A. G., de Jong, P. T. V. M., Cree, A. J., Griffiths, H., Rivadeneira, F., et al. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2009.08.032 · Cited by 48
Self-citationSchnabolk, G., Parsons, N., Obert, E., Annamalai, B., Nasarre, C., Tomlinson, S., Lewin, A. S., & Rohrer, B. (2018) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2017.11.003 · Cited by 39
The Pathophysiology of Cigarette Smoking and Age-Related Macular Degeneration
Dhubhghaill, S. N., Cahill, M. T., Campbell, M., Cassidy, L., Humphries, M. M., & Humphries, P. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1399-9_50 · Cited by 46
“A number of genetic risk factors associated with AMD are involved in the activation and regulation of the complement pathway and thus far, SNPs in complement components C3, CFH, C2 and Factor B have been implicated in the pathogenesis of AMD (Haines et al. 2005; Gold et al. 2006; Yates et al. 2007).”
BackgroundInteraction of Complement Factor H and Fibulin3 in Age-Related Macular Degeneration
Wyatt, M. K., Tsai, J.-Y., Mishra, S., Campos, M., Jaworski, C., Fariss, R. N., Bernstein, S. L., & Wistow, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068088 · Cited by 41
Farwick, A., Dasch, B., Weber, B. H. F., Pauleikhoff, D., Stoll, M., & Hense, H.-W. (2009) · Eye · doi:10.1038/eye.2008.426 · Cited by 48
Genome-wide analysis of copy number variants in age-related macular degeneration
Meyer, K. J., Davis, L. K., Schindler, E. I., Beck, J. S., Rudd, D. S., Grundstad, A. J., Scheetz, T. E., Braun, T. A., Fingert, J. H., Alward, W. L. M., et al. (2010) · Human Genetics · doi:10.1007/s00439-010-0904-6 · Cited by 43
“Candidate gene studies have revealed associations with additional complement pathway genes, including BF (Gold et al. 2006), C2 (Gold et al. 2006; Maller et al. 2006), C3 (Maller et al. 2007; Yates et al. 2007), CFI (Fagerness et al. 2009), CFHR1 (Hughes et al. 2006), CFHR3 (Hughes et al. 2006),…”
Rohrer, B., Coughlin, B. A., Bandyopadhyay, M., & Holers, V. M. (2012) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2011.0212 · Cited by 44
Age-Related Macular Degeneration: A Disease of Systemic or Local Complement Dysregulation?
Warwick, A., Khandhadia, S., Ennis, S., & Lotery, A. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3041234 · Cited by 41
“Several further risk variants in complement-related genes have since been discovered, including C2/CFB [13], C3 [14], possibly C7 [15], C9 [16], CFI [17] and SERPING [18], although some controversy exists over the significance of the latter [19].”
Retinal pigment epithelial cells mitigate the effects of complement attack by endocytosis of C5b-9
Georgiannakis, A., Burgoyne, T., Lueck, K., Futter, C., Greenwood, J., & Moss, S. E. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500937 · Cited by 41
Zinc-induced Self-association of Complement C3b and Factor H
Nan, R., 南, 若., Tetchner, S., Rodriguez, E., Pao, P.-J., 鮑, 柏., Gor, J., Lengyel, I., & Perkins, S. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.476143 · Cited by 39
Dry age-related macular degeneration: A currently unmet clinical need
Girmens, J. (2012) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2012.v1.3.103 · Cited by 47
“Another member of the complement system, factor B, has also been shown to have both high-risk and protective variants associated with the development of AMD (23).”
BackgroundGene Ontology and KEGG Enrichment Analyses of Genes Related to Age-Related Macular Degeneration
Zhang, J., Xing, Z., Ma, M., Wang, N., Cai, Y., Chen, L., & Xu, X. (2014) · BioMed Research International · doi:10.1155/2014/450386 · Cited by 45
“Several complement genes including complement 2 (C2) and complement 3 (C3) have been strongly associated with AMD [12, 68].”
BackgroundRetinal disease in the C3 glomerulopathies and the risk of impaired vision
Savige, J., Amos, L., Ierino, F. L., Mack, H. G., Symons, R. C. A., Hughes, P., Nicholls, K., & Colville, D. (2016) · Ophthalmic Genetics · doi:10.3109/13816810.2015.1101777 · Cited by 43
Dense deposit disease: new insights
Walker, P. D. (2007) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3280bdc0f4 · Cited by 42
Nakata, I., Yamashiro, K., Yamada, R., Gotoh, N., Nakanishi, H., Hayashi, H., Akagi-Kurashige, Y., Tsujikawa, A., Otani, A., Saito, M., et al. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8468 · Cited by 41
Dynamic control of the complement system by modulated expression of regulatory proteins
Thurman, J. M., & Renner, B. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.173 · Cited by 41
“AMD is associated with polymorphisms in factor H and factor B, suggesting that impaired control of the alternative pathway contributes to injury in this disease.(41,42) Patients with dense deposit disease may also develop retinal lesions similar to those seen in AMD, further supporting a link between impaired compleme…”
BackgroundGraßmann, F., Friedrich, U., Fauser, S., Schick, T., Milenkovic, A., Schulz, H. L., von Strachwitz, C. N., Bettecken, T., Lichtner, P., Meitinger, T., et al. (2015) · NeuroMolecular Medicine · doi:10.1007/s12017-015-8342-1 · Cited by 45
“…note, many of these loci suggest an involvement of inflammatory processes and impaired complement activation in AMD pathogenesis (Klein et al. 2005; Gold et al. 2006; Yates et al. 2007; Hughes et al. 2007; Fagerness et al. 2009), a fact that has raised major interest in novel therapeutic approaches…”
BackgroundSelf-citationPark, K. H., Ryu, E., Tosakulwong, N., Wu, Y., & Edwards, A. O. (2009) · PubMed Central · Cited by 45
Correction: Systemic Complement Activation in Age-Related Macular Degeneration
Scholl, H. P. N., Charbel Issa, P., Walier, M., Janzer, S., Pollok-Kopp, B., Börncke, F., Fritsche, L. G., Chong, N. V., Fimmers, R., Wienker, T., et al. (2008) · PLoS ONE · doi:10.1371/annotation/32b9bc31-ed6d-4d31-9ce0-480407017bad · Cited by 39
Zerbib, J., Seddon, J. M., Richard, F., Reynolds, R., Leveziel, N., Benlian, P., Borel, P., Feingold, J., Münnich, A., Soubrane, G., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007341 · Cited by 58
van de Ven, J. P. H., Smailhodzic, D., Boon, C. J. F., Fauser, S., Groenewoud, J. M. M., Chong, V. N., Hoyng, C. B., Klevering, B. J., & den Hollander, A. I. (2012) · Europe PMC (PubMed Central) · Cited by 47
Scheetz, T. E., Fingert, J. H., Wang, K., Kuehn, M. H., Knudtson, K. L., Alward, W. L. M., Boldt, H. C., Russell, S. R., Folk, J. C., Casavant, T. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058657 · Cited by 41
Treatment of Dry Age-Related Macular Degeneration
Querques, G., Rosenfeld, P. J., Cavallero, E., Borrelli, E., Corvi, F., Querques, L., Bandello, F. M., & Zarbin, M. A. (2014) · Ophthalmic Research · doi:10.1159/000363187 · Cited by 41
Complement pathway biomarkers and age-related macular degeneration
Gemenetzi, M. K., & Lotery, A. J. (2015) · Eye · doi:10.1038/eye.2015.203 · Cited by 41
Rajeevan, M. S., Dimulescu, I. M., Murray, J., Falkenberg, V. R., & Unger, E. R. (2015) · Human Immunology · doi:10.1016/j.humimm.2015.06.014 · Cited by 39
Sugino, I. K., Gullapalli, V. K., Sun, Q., Wang, J., Nunes, C. F., Cheewatrakoolpong, N., Johnson, A. C., Degner, B. C., Hua, J., Liu, T., et al. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6112 · Cited by 40
Graydon, R., Hogg, R. E., Chakravarthy, U., Young, I. S., & Woodside, J. V. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114511005599 · Cited by 43
Age-Related Macular Degeneration and the Risk of Stroke: The Rotterdam Study
Wieberdink, R. G., Ho, L., Ikram, M. K., Koudstaal, P. J., Hofman, A., de Jong, P. T. V. M., Vingerling, J. R., & Breteler, M. M. B. (2011) · Stroke · doi:10.1161/strokeaha.111.616359 · Cited by 46
Age-related Macular Degeneration and Complement Activation–related Diseases
Nitsch, D., Douglas, I., Smeeth, L. L., & FLETCHER, A. E. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.06.035 · Cited by 43
Complement inhibitors for age-related macular degeneration
Tzoumas, N., Riding, G., Williams, M. A., & Steel, D. H. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009300.pub3 · Cited by 38
Ramo, K., Cashman, S. M., & Kumar-Singh, R. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2025 · Cited by 38
Hou, S., Qi, J., Liao, D., Zhang, Q., Fang, J., Zhou, Y. N., Liu, Y., Bai, L., Zhang, M., Kijlstra, A., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38116 · Cited by 40
de Córdoba, S. R., Harris, C. L., Morgan, B. P., & Llorca, Ó. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.09.002 · Cited by 44
PHARMACOGENOMICS OF RESPONSE TO ANTI-VEGF THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION
Dedania, V. S., Grob, S., Zhang, K., & Bakri, S. J. (2015) · Retina · doi:10.1097/iae.0000000000000466 · Cited by 38
Update on Geographic Atrophy in Age‐Related Macular Degeneration
Biarnés, M., Monés, J., Alonso, J., & Arias, L. (2011) · Optometry and Vision Science · doi:10.1097/opx.0b013e31821988c1 · Cited by 41
van Asten, F., Simmons, M., Singhal, A., Keenan, T. D., Ratnapriya, R., Agrón, E., Clemons, T. E., Swaroop, A., Lu, Z., & Chew, E. Y. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2017.09.023 · Cited by 38
Graßmann, F., Fauser, S., & Weber, B. H. F. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.04.039 · Cited by 41
Systems genomics in age-related macular degeneration
den Hollander, A. I., Mullins, R. F., Orozco, L. D., Voigt, A. P., Chen, H.-H., Strunz, T., Graßmann, F., Haines, J. L., Kuiper, J. J. W., Tumminia, S. J., et al. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2022.109248 · Cited by 39
Self-citationHeredity of Small Hard Drusen in Twins Aged 20–46 Years
Munch, I. C., Sander, B., Kessel, L., Hougaard, J. L., Taarnhøj, N. C. B. B., Sørensen, T. I. A., Kyvik, K. O., & Larsen, M. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0529 · Cited by 42
Paun, C. C., Lechanteur, Y. T. E., Groenewoud, J. M. M., Altay, L., Schick, T., Daha, M. R., Fauser, S., Hoyng, C. B., den Hollander, A. I., & de Jong, E. K. (2016) · Scientific Reports · doi:10.1038/srep26568 · Cited by 37
Yip, J. L. Y., Khawaja, A. P., Chan, M. P. Y., Broadway, D. C., Pető, T., Tufail, A., Luben, R., Hayat, S. A., Bhaniani, A., Wareham, N. J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132565 · Cited by 42
“A variety of raised inflammatory markers and genes in the complement pathway, including complement factor H (CFH),[35,36] complement factor B/complement component 2 (CFB/C2),[37] complement 3 (C3),[38] and complement factor I (CFI)[39] are associated with increased risk of AMD.”
BackgroundSchnabolk, G., Coughlin, B., Joseph, K., Kunchithapautham, K., Bandyopadhyay, M., O'Quinn, E. C., Nowling, T., & Rohrer, B. (2015) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.14-15910 · Cited by 37
The Role of Complement Dysregulation in Glaucoma
Hoppe, C., & Gregory-Ksander, M. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042307 · Cited by 38
“Interestingly, the alternative pathway has also been linked to other neurodegenerative diseases such as age-related macular degeneration [30,31], as well as spinal cord and brain injuries [125,126], while the lectin pathway has been linked to brain ischemia [29].”
BackgroundAge-related macular degeneration: current treatment and future options
Moutray, T., & Chakravarthy, U. (2011) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622311415895 · Cited by 39
“A protective deletion of CFHR1 and 24CFHR3 occurs close to the CFH locus in 8% of AMD patients [Hughes et al. 2006] and a protective haplotype, reducing the risk of AMD, is associated with variation in complement factors C2 and factor B [Gold et al. 2006].”
BackgroundClusterin in the eye: An old dog with new tricks at the ocular surface
Fini, M. E., Bauskar, A., Jeong, S., & Wilson, M. R. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2016.04.019 · Cited by 40
“are associated with increased disease risk [94-97], but no variants in CLU have yet been associated with disease.”
BackgroundClusterin, other extracellular chaperones, and eye disease
Wilson, M. R., Satapathy, S., Jeong, S., & Fini, M. E. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.101032 · Cited by 42
Bazan, N. G., Calandria, J. M., & Gordon, W. C. (2013) · Nestlé Nutrition Institute Workshop series · doi:10.1159/000351395 · Cited by 39
Ferrara, D., Merriam, J. E., Freund, K. B., Spaide, R. F., Takahashi, B. S., ZHITOMIRSKY, I., Fine, H. F., Yannuzzi, L. A., & Allikmets, R. (2008) · Archives of Ophthalmology · doi:10.1001/archopht.126.11.1562 · Cited by 40
“The CFB protein has been identified in drusen, Bruch membrane, and, less prominently, choroidal stroma.(28) Surprisingly, the CFB variants were not found to be protective in our MFC cohort because the frequency of the 2 haplotype-tagging SNPs was similar to that of the control group and statistically significantly dif…”
BackgroundResultInfluentialGenetic association study of age-related macular degeneration in the Spanish population
Brión, M., Sánchez‐Salorio, M., Cortón, M., de la Fuente, M., Pazos, B., Othman, M., Swaroop, A., Abecasis, G. R., Sobrino, B., & Carracedo, Á. (2010) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2010.02040.x · Cited by 40
“In addition, several complement genes have recently been also associated with AMD susceptibility, including complement factor B (CFB), complement 2 (C2), and complement 3 (C3) genes (Gold et al. 2006; Maller et al. 2007; Yates et al. 2007).”
Inflammatory Biomarkers for AMD
Stanton, C. M., & Wright, A. F. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3209-8_32 · Cited by 42
Anti-VEGF agents for age-related macular degeneration
Özkırış, A. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770902762885 · Cited by 39
“Conversely, protective effects were reported for polymorphisms in the complement factor B and complement component 2 genes on chromosome 6 and various haplotypes on the CFH gene [14].”
BackgroundAllergy Is a Protective Factor Against Age-Related Macular Degeneration
Ristau, T., Ersoy, L., Lechanteur, Y. T. E., den Hollander, A. I., Daha, M. R., Hahn, M., Hoyng, C. B., & Fauser, S. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13248 · Cited by 43
Cardon, L. R. (2006) · Science · doi:10.1126/science.1136668 · Cited by 36
Melville, H., Carpiniello, M. F., Hollis, K., Staffaroni, A., & Golestaneh, N. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-53 · Cited by 38
“Polymorphisms on chromosome 1 in complement factor H (CFH) [41], complement 2 (C2), complement factor B (CFB), complement 3 (C3), complement factor H-related gene (CFHR1) and complement factor I (CFI) are associated with increased risk of developing AMD [42-48].”
BackgroundAssociations of IL-23 with Polypoidal Choroidal Vasculopathy
Sasaki, S.-I., Miyazaki, D., Miyake, K.-I., Terasaka, Y., Kaneda, S., Ikeda, Y., Funakoshi, T., Baba, T., Yamasaki, A., & Inoue, Y. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7913 · Cited by 35
Maugeri, A., Barchitta, M., Mazzone, M. G., Giuliano, F., & Agodi, A. (2018) · BioMed Research International · doi:10.1155/2018/7532507 · Cited by 36
“Indeed, some common haplotypes, spanning CFB and C2 genes, are considered highly protective against AMD [122].”
BackgroundMarin, A. I., Poppelaars, F., Wagner, B. D., Palestine, A. G., Patnaik, J. L., Holers, V. M., Frazer‐Abel, A. A., Mathias, M. T., Manoharan, N., Fonteh, C. N., et al. (2022) · Translational Vision Science & Technology · doi:10.1167/tvst.11.5.22 · Cited by 37
Yednock, T. A., Fong, D. S., & Lad, E. M. (2022) · International Journal of Retina and Vitreous · doi:10.1186/s40942-022-00431-y · Cited by 38
Complement Involvement in Neovascular Ocular Diseases
Yanai, R., Thanos, A., & Connor, K. M. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0106-3_10 · Cited by 38
Kainz, A., Perco, P., Mayer, B., Soleiman, A., Steininger, R., Mayer, G. J., Mitterbauer, C., Schwarz, C. C., Meyer, T. W., & Oberbauer, R. W. (2007) · Transplantation · doi:10.1097/01.tp.0000259960.56786.ec · Cited by 35
“Other genes that might be differentially regulated during the ageing are ITGAV (28), BF (29), PLA2G12B (30, 31), and MT1H (32).”
BackgroundLXIII Edward Jackson Memorial Lecture: Eye Care: Dollars and Sense
Taylor, H. R. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.10.003 · Cited by 35
Implications of altered iron homeostasis for age-related macular degeneration
Błasiak, J. (2010) · Frontiers in bioscience · doi:10.2741/3804 · Cited by 41
NEIBank: genomics and bioinformatics resources for vision research.
Wistow, G. J., Peterson, K. M., Gao, J., Buchoff, P., Jaworski, C. J., Rickman, C. B., Ebright, J. N., Hauser, M. A., & Hoover, D. (2008) · PubMed Central · Cited by 34
Innate Immunity: A Balance between Disease and Adaption to Stress
Faenza, I., & Blalock, W. L. (2022) · Biomolecules · doi:10.3390/biom12050737 · Cited by 36
“Moreover, similar to C9, diverse variants of C2 and C3 proteins are associated with age-related macular degeneration [63,73].”
BackgroundPlatelet genomics and the risk of atherothrombosis
Ouwehand, W. H. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02550.x · Cited by 35
Copy number variation in the complement factor H-related genes and age-related macular degeneration.
Schmid‐Kubista, K. E., Tosakulwong, N., Wu, Y., Ryu, E., Roeder, J. L., Hecker, L. A., Baratz, K. H., Brown, W. L., & Edwards, A. O. (2011) · PubMed Central · Cited by 40
Keilhauer, C. N., Fritsche, L. G., Guthoff, R., Haubitz, I., & Weber, B. H. F. (2012) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2012.10.005 · Cited by 37
Susceptibility Genes and Progression in Age-Related Maculopathy: A Study of Single Eyes
Farwick, A., Wellmann, J., Stoll, M., Pauleikhoff, D., & Hense, H. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-3953 · Cited by 37
Peter, I., Huggins, G. S., Ordovás, J. M., Haan, M. N., & Seddon, J. M. (2011) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2011.05.016 · Cited by 35
Current Treatment of Age‐Related Macular Degeneration
Zarbin, M. A., & Szirth, B. C. (2007) · Optometry and Vision Science · doi:10.1097/opx.0b013e3180de4dd7 · Cited by 38
Dinu, V., Zhao, H., & Miller, P. L. (2007) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2007.06.002 · Cited by 35
Tzoumas, N., Hallam, D., Harris, C. L., Lako, M., Kavanagh, D., & Steel, D. H. W. (2021) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2020.10.008 · Cited by 33
Genetic Factors Associated with Age-Related Macular Degeneration
Leveziel, N., Tilleul, J., Puche, N., Zerbib, J., Lalloum, F., Querques, G., & Souied, E. H. (2011) · Ophthalmologica · doi:10.1159/000328981 · Cited by 40
Douillard, A., Picot, M., Delcourt, C., Defoort‐Dhellemmes, S., Marzouka, N., Lacroux, A., Zanlonghi, X., Drumare, I., Jozefowicz, E., Bocquet, B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-25003-9 · Cited by 36
Robman, L. D., Mahdi, O. S., Wang, J. J., Burlutsky, G., Mitchell, P., Byrne, G. I., Guymer, R. H., & Taylor, H. R. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-1434 · Cited by 35
Association of C2 and CFB Polymorphisms with Anterior Uveitis
Yang, M., Lai, T. Y. Y., Tam, P. O. S., Chiang, S. W. Y., Ng, T. K., Liu, K., & Pang, C. P. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9478 · Cited by 37
Metadata
- Authors
- The AMD Genetics Clinical Study Group, Gold, B., Merriam, J. E., Zernant, J., Hancox, L. S., Taiber, A. J., Gehrs, K., Cramer, K., Neel, J., Bergeron, J., Barile, G. R., Smith, R. T., Hageman, G. S., Dean, M., & Allikmets, R.
- Affiliations
- National Cancer Institute (US)
- Columbia University (US)
- University of Iowa (US)
- Science Applications International Corporation (United States) (US)
- Corresponding author
- Dean, Michael
- Allikmets, Rando
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-03-05
- Volume
- 38
- Issue
- 4
- Pages
- 458-462
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC2921703
- OpenAlex
- W1997288094
- Cited by
- 1,075
- References
- 31
- Citations by year
- 2026: 17 · 2025: 17 · 2024: 18 · 2023: 17 · 2022: 27 · 2021: 40 · 2020: 33 · 2019: 28 · 2018: 27 · 2017: 31 · 2016: 47 · 2015: 65 · 2014: 74 · 2013: 69 · 2012: 90
- FWCI
- 85.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Eye Institute (EY11515, R01EY013435, EY-13435, R01EY015520, R01EY011515)
- National Cancer Institute (N01-CO-124000)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- age-related macular degeneration, factor B, alternative complement pathway, genetic risk variants, haplotypes, complement factor H, MHC class III, genetic susceptibility
- MeSH terms
- Aged, Aged, 80 and over, Aging, Chromatography, High Pressure Liquid, Complement C2, Haplotypes, Humans, Immunohistochemistry, Macular Degeneration, Molecular Sequence Data, Complement Factor B, Cohort Studies, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.